
The World Health Organization (WHO) classified EG.5, which has been nicknamed by some as "Eris", as a "variant of interest," indicating that it should be more closely watched than others because of mutations that might make it more contagious or severe.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/IvEWbmx
via
IFTTT
0 comments:
Post a Comment